NAICS 325413 - In-Vitro Diagnostic Substance Manufacturing
What is NAICS 325413
Industry Classification for NAICS 325413
This U.S. industry comprises establishments primarily engaged in manufacturing in-vitro (i.e., not taken internally) diagnostic substances, such as chemical, biological, or radioactive substances. The substances are used for diagnostic tests that are performed in test tubes, petri dishes, machines, and other diagnostic test-type devices.
Breakdown for NAICS 325413
- Manufacturing of chemical, biological, or radioactive diagnostic substances used outside the human body.
- Includes products such as reagents, assay kits, and diagnostic consumables.
- Supports diagnostic tests performed in laboratory devices like test tubes and petri dishes.
- Typical small business size standard is based on employee count or revenue thresholds set by SBA.
- Contracts often require compliance with FDA regulations and quality standards.
- Critical to public health, biodefense, and clinical research initiatives.
Included Activities for NAICS 325413
- Producing chemical reagents for diagnostic assays.
- Manufacturing biological substances used in diagnostic testing.
- Formulating radioactive substances for diagnostic applications.
- Packaging and labeling in-vitro diagnostic test kits.
- Ensuring regulatory compliance and quality assurance for diagnostic products.
- Supplying diagnostic consumables to clinical laboratories and government health agencies.
- Custom developing diagnostic substances for specialized testing applications.
- Conducting stability and efficacy testing on manufactured diagnostic substances.
Business Types for NAICS 325413
- Specialized diagnostic reagent manufacturers.
- Biotechnology firms producing assay components.
- Contract manufacturing organizations (CMOs) for diagnostic substances.
- Small and medium-sized enterprises focused on in-vitro diagnostics.
- Laboratory supply companies with manufacturing capabilities.
- Research and development companies in diagnostic technology.
Subcategories for NAICS 325413
- Blood derivative in-vitro diagnostic substances manufacturing
- Blood glucose test kits manufacturing
- Coagulation in-vitro diagnostic substances manufacturing
- Cytology and histology in-vitro diagnostic substances manufacturing
- Diagnostic substances, in-vitro, manufacturing
- Enzyme and isoenzyme in-vitro diagnostic substances manufacturing
- Hematology in-vitro diagnostic substances manufacturing
- HIV test kits manufacturing
- Hormone in-vitro diagnostic substances manufacturing
- In-vitro diagnostic substances manufacturing
- Microbiology, virology, and serology in-vitro diagnostic substances manufacturing
- Pregnancy test kits manufacturing
- Viral in-vitro diagnostic test substances manufacturing
Government Buyers for NAICS 325413
Contract Types & Procurement for NAICS 325413
Details for NAICS 325413
Explore the hierarchy and related codes for this industry
| NAICS Code | Industry Title |
|---|---|
| 32541 | Pharmaceutical and Medicine Manufacturing |
| 3254 | Pharmaceutical and Medicine Manufacturing |
| 325 | Chemical Manufacturing |
Find In-Vitro Diagnostic Substance Manufacturing Contract Opportunities
Access federal solicitations, track award history, and monitor agency spend in this industry in one place. Designed to support small businesses pursuing federal revenue.
- Opportunities updated regularly from SAM.gov
- Filter by set-aside, agency, NAICS, and PSC
- Get notified when matching opportunities are posted
30 minutes • Discuss your goals with our team
Leverage Your Certifications for a Competitive Edge
Our federal contracting specialists can help businesses build certifications and capability statements to pursue opportunities in industries like In-Vitro Diagnostic Substance Manufacturing .
- WOSB, VOSB & 8(a) certification support
- Capability statement writing & review
- SAM.gov registration & compliance guidance
Discover Your Next Industry Opportunity
Browse thousands of NAICS codes across every federal procurement sector. Find industries aligned with your capabilities and uncover where government spending is concentrated.